4//SEC Filing
Auster Martin 4
Accession 0001209191-23-048632
CIK 0001851194other
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 4:31 PM ET
Size
8.8 KB
Accession
0001209191-23-048632
Insider Transaction Report
Form 4
Auster Martin
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-09-05$32.26/sh−18,327$591,183→ 29,322 total - Sale
Common Stock
2023-09-05$33.41/sh−8,142$272,049→ 21,180 total - Sale
Common Stock
2023-09-05$33.98/sh−3$102→ 21,177 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2022.
- [F2]Represents the weighted average share price of an aggregate total of 18,327 shares sold in the price range of $31.97 to $32.8321. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average share price of an aggregate total of 8,142 shares sold in the price range of $32.97 to $33.96. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Ventyx Biosciences, Inc.
CIK 0001851194
Entity typeother
Related Parties
1- filerCIK 0001875786
Filing Metadata
- Form type
- 4
- Filed
- Sep 6, 8:00 PM ET
- Accepted
- Sep 7, 4:31 PM ET
- Size
- 8.8 KB